Pregnancy and multiple sclerosis: the initial results from a Brazilian database

• Autor(a) principal: Fragoso,Yara Dadalti
• Data de Publicação: 2009
• Outros Autores: Finkelsztejn,Alessandro, Comini-Frota,Elizabeth Regina, Gama,Paulo Diniz da, Grzesiuk,Ansderson Kuntz, Khouri,Jussara Mathias Netto, Alves-Leon,Soniza Vieira, Morales,Rogério de Rizo, Lana-Peixoto,Marco Aurélio, Rocha,Cristiane Franklin da
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Arquivos de neuro-psiquiatria (Online)
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2009000400015
• topic: multiple sclerosis; pregnancy; prematurity; low birth weight; obstetric complications; interferon beta; glatiramer acetate

PURPOSE: Pregnancy management poses an extra challenge to physicians and their multiple sclerosis (MS) patients. There are few papers reporting databases on the subject. METHOD: Brazilian database from nine MS clinical and research units, with complete data on 47 pregnant women (49 pregnancies). RESULTS: Despite relatively high exposure to MS medications, no birth defects were reported. Low birth weight and prematurity were similar to those for developing countries. Three complications may have been associated with these medications, while three others were considered to be of purely obstetric nature. CONCLUSION: Our results confirm previous findings on lower relapse rate during pregnancy and add to the present literature informing on data related to drug exposure.